Home / ha ha / Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

May 20, 2024 ha ha

Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

Reviewed by karthi on May 20, 2024 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )